Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease

NCT02177344 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

646

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Low dose of Ipratropium bromide
DRUG: High dose of Ipratropium bromide
DRUG: Atrovent
DRUG: Placebo

Sponsor

Boehringer Ingelheim